​

Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CPIX Stock Rating

Cumberland Pharmaceuticals stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (60.00%), 2 Hold (40.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 2 3 Strong Sell Sell Hold Buy Strong Buy

CPIX Price Target Upside V Benchmarks

TypeNameUpside
StockCumberland Pharmaceuticals-
SectorHealthcare Stocks 23.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$5.86$5.86$5.86
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24--1--1
Oct, 24--1--1
Sep, 24--1--1
Aug, 24--1--1
Jul, 24--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 26 Dec 27 Dec 28 Dec 29 Dec 30
Dec 20Dec 21Dec 22Dec 23Dec 26Dec 27Dec 28Dec 29Dec 30
Reported$-0.44$-0.38$-0.39$-0.44-----
Avg Forecast$-0.22$-0.03$-0.23$-0.96$-0.55$-0.31$-0.22$-0.03$-0.23
High Forecast$-0.22$-0.03$-0.23$-0.76$-0.55$-0.31$-0.22$-0.03$-0.23
Low Forecast$-0.22$-0.03$-0.23$-1.15$-0.55$-0.31$-0.22$-0.03$-0.23
Surprise %100.00%1166.67%69.57%-54.17%-----

Revenue Forecast

$35M $43M $51M $59M $67M $75M Dec 20 Dec 21 Dec 22 Dec 23 Dec 26 Dec 27 Dec 28 Dec 29 Dec 30
Dec 20Dec 21Dec 22Dec 23Dec 26Dec 27Dec 28Dec 29Dec 30
Reported$37.44M$35.99M$42.01M$39.55M-----
Avg Forecast$36.96M$40.97M$44.85M$61.23M$38.23M$45.20M$36.96M$40.97M$44.85M
High Forecast$36.96M$40.97M$44.85M$73.48M$38.23M$45.20M$36.96M$40.97M$44.85M
Low Forecast$36.96M$40.97M$44.85M$48.98M$38.23M$45.20M$36.96M$40.97M$44.85M
Surprise %1.30%-12.16%-6.34%-35.40%-----

Net Income Forecast

$-8M $-6M $-5M $-3M $-2M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 26 Dec 27 Dec 28 Dec 29 Dec 30
Dec 20Dec 21Dec 22Dec 23Dec 26Dec 27Dec 28Dec 29Dec 30
Reported$-6.63M$-5.60M$-5.65M$-6.28M-----
Avg Forecast$-3.15M$-4.16M$-4.42M$-3.67M$-7.73M$-4.36M$-3.09M$-421.81K$-3.23M
High Forecast$-3.15M$-2.31M$-2.42M$-1.71M$-7.73M$-4.36M$-3.09M$-421.81K$-3.23M
Low Forecast$-3.15M$-6.00M$-6.42M$-5.64M$-7.73M$-4.36M$-3.09M$-421.81K$-3.23M
Surprise %110.63%34.64%27.83%71.02%-----

CPIX Forecast FAQ

Is Cumberland Pharmaceuticals stock a buy?

Cumberland Pharmaceuticals stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cumberland Pharmaceuticals is a favorable investment for most analysts.

What is Cumberland Pharmaceuticals's price target?

Cumberland Pharmaceuticals's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $5.86.

How does Cumberland Pharmaceuticals stock forecast compare to its benchmarks?

Cumberland Pharmaceuticals's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the specialty & generic drug manufacturers stocks industry (28.78%).

What is the breakdown of analyst ratings for Cumberland Pharmaceuticals over the past three months?

  • November 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Cumberland Pharmaceuticals’s EPS forecast?

Cumberland Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.55, marking a 25.00% increase from the reported $-0.44 in 2025. Estimates for the following years are $-0.31 in 2027, $-0.22 in 2028, $-0.03 in 2029, and $-0.23 in 2030.

What is Cumberland Pharmaceuticals’s revenue forecast?

Cumberland Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2026 is $38.22M, reflecting a -3.36% decrease from the reported $39.55M in 2025. The forecast for 2027 is $45.2M, followed by $36.96M for 2028, $40.97M for 2029, and $44.85M for 2030.

What is Cumberland Pharmaceuticals’s net income forecast?

Cumberland Pharmaceuticals's net income forecast for the fiscal year ending in December 2026 stands at $-7.733M, representing an 23.15% increase from the reported $-6.279M in 2025. Projections indicate $-4.359M in 2027, $-3.093M in 2028, $-422K in 2029, and $-3.234M in 2030.